US 9562088
Pegylated CD154 peptides and methods of inhibiting CD40 interacations with CD154
granted A61KA61K38/08A61K38/10
Quick answer
US patent 9562088 (Pegylated CD154 peptides and methods of inhibiting CD40 interacations with CD154) held by The Regents of the University of Colorado, a Body Corporate expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K38/08, A61K38/10, A61K38/1774